Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03807349 · ClinicalTrials.gov registry record · NA
N-Force Screws Augmented With N-Force Blue in Hip Fractures
A NA study, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03807349: Clinical Trial NA study, sponsored by Zimmer Biomet.
NCT03807349 is a NA study that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03807349, a NA study, was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The objective of this prospective study is to confirm safety and performance of N-Force Screws augmented with N-Force Blue applied in intracapsular proximal femur fracture treatment.
Primary Outcome
Reoperation after initial surgery to promote fracture healing, relieve pain, treat infection, or improve function.
Interventions
- DEVICE N-Force Screws Augmented with N-Force Blue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-02-21 |
| Est. Completion | 2021-03-11 |
| Phase | NA |
Why NCT03807349 stopped before completion
NCT03807349 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which N-Force Screws Augmented with N-Force Blue is the first listed.
NCT03807349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03807349 about?
NCT03807349 is a clinical study titled "N-Force Screws Augmented With N-Force Blue in Hip Fractures". The objective of this prospective study is to confirm safety and performance of N-Force Screws augmented with N-Force Blue applied in intracapsular proximal femur fracture treatment.
What is the current status of trial NCT03807349?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2019-02-21. Estimated completion is 2021-03-11.
What interventions are being tested in trial NCT03807349?
The interventions under investigation include: N-Force Screws Augmented with N-Force Blue (DEVICE).
Who is sponsoring clinical trial NCT03807349?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03807349's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI